Raymond James analyst Chris Raymond downgraded Sionna Therapeutics (NASDAQ: SION) from Outperform to Market Perform.The analyst comments "Downgrading SION shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE